Drug intelligence / Profile preview

Hyodeoxycholic acid

Development stage
Phase 1
Lead developer
AtheroNova
Modality
Small Molecules
Administration
Oral
01

Overview

Hyodeoxycholic acid is a secondary bile acid and a small molecule drug. It is naturally present in various mammalian species and is the main bile acid constituent of hog bile. Industrially, it was historically used as a precursor for steroid synthesis. Pharmacologically, hyodeoxycholic acid acts as a receptor-specific activator of nuclear liver X receptor alpha (LXRalpha), which regulates the expression of cholesterol 7alpha-hydroxylase and plays an important role in cholesterol metabolism. Through LXR activation and related pathways, it increases the efficiency of cholesterol efflux via HDL cells and may reduce arterial plaque formation. Hyodeoxycholic acid has been investigated for its potential to treat hypercholesterolemia and atherosclerosis; clinical trials have reached phase I for these indications[1][2][4][5]. The compound has also been explored for use in metabolic disorders and liver diseases[8].

Other names
3α,6α-dihydroxy-5β-cholan-24-oic acidACIDUM HYODESOXYCHOLCUMTabellae Acidi Hyodesoxycholici
02

Targets

NR1H3 (Liver X receptor beta)GPBAR1CYP7A1 (Cholesterol 7alpha-hydroxylase)

Beyond the preview

Go deeper on Hyodeoxycholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyodeoxycholic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call